期刊文献+

经皮椎体成形术联合鲑鱼降钙素治疗骨质疏松椎体压缩性骨折的临床观察 被引量:20

The clinical observation of percutaneous vertebroplasty combined with salmon calcitonin for the treatment of osteoporotic vertebral compression fracture
下载PDF
导出
摘要 目的通过对比研究,观察经皮椎体成形术联合密盖息治疗骨质疏松性椎体压缩骨折的疗效。方法 2008年2月至2011年1月,我们将脊柱压缩性骨折行PVP手术患者随机分成两组,治疗组在术后当日予以肌注鲑鱼降钙素,治疗3周后改用鼻喷剂,连续使用至少3个月;观察组单纯予以椎体成形术,分别在术前,术后1周,1月,3月以及6月采用VAS评分以及Barthel指数来评估两组治疗效果。结果两组患者均在术后疼痛均有明显的缓解,但是相对于观察组,治疗组在术后1月,3月,以及6月疼痛缓解以及生活质量提高更为明显,随着随访时间的延长,这种差别越来越明显。结论椎体成形术结合鲑鱼降钙素治疗骨质疏松性椎体压缩性骨折更能缓解患者的疼痛,提高患者的生活质量,值得临床推广。 Objective To observe percutaneous vertebroplasty(PVP) combined with salmon calcitonin for the treatment of patients with osteoporotic vertebral compression fracture(OVCF) through comparative research.Methods The OVCF patients treated with PVP from Feb 2008 to Jan 2011 were randomly divided into two groups.The patients in treatment group were treated with intramuscular injection of salmon calcitonin after the operation for 3 weeks and nasal spray of salmon calcitonin after that at least for 3 months.The patients in control group were treated with PVP only.The clinical efficacies of the two groups were assessed with the visual analogue pain score(VAS) and the capability of living score(Barthel Index) before the operation,and 1 week,1 month,3 months,and 6 months after the operation,respectively.Results Pain of patients in both two groups was relieved significantly.However,the pain relieve at 1-,3-,and 6-month after the operation and the improvement of life quality in the treatment group were more significant than those in the control group.This difference became more significant along with the follow up time.Conclusion PVP combined with salmon calcitonin can effectively relieve the pain of OVCF patients and improve their life quality.It is worthy of clinical promotion.
出处 《中国骨质疏松杂志》 CAS CSCD 北大核心 2012年第1期36-39,共4页 Chinese Journal of Osteoporosis
关键词 经皮椎体成形术 鲑鱼降钙素 骨质疏松 椎体压缩性骨折 Percutaneous vertebroplasty(PVP) Salmon calcitonin Compression fracture Osteoporosis
  • 相关文献

参考文献13

  • 1Old JL,Calvert M.Vertebral compression fractures in theelderly.Am Fam Physician,2004,69(1):111-116.
  • 2Lieberrnan IH,Dudeney S,Reinbardt MK,et al.Initial outcome andefficacy of“kyphoplasty”in the treatment of painful osteoporoticvertebral compression fracture.Spine,2001,26(14):1631-1638.
  • 3Buchbinder R,Osborne RH,Ebeling PR,et al.A RandomizedTrial of Vertebroplasty for Painful Osteoporotic VertebralFractures.N Engl J Med,2009,361(6):557-568.
  • 4Barr JD,Barr MS,Lemley TJ,et al.Percutaneous vertebroplasty forpain relief and spinal stabilization.Spine,2000,25(8):923-928.
  • 5Diamond TH,Champion B,Clark WA.Clinical outcomes afteracute osteoporotic vertebral fractures:a 2-year non-randomisedtrial comparing pereutaneous vertebroplasty with conservativetherapy.Medical Journal of Australia,2006,184(3):113-117.
  • 6Voormolen MH,Lohle PN,Juttmann JR,et al.The risk of newosteoporotic vertebral compression fractures in the year afterpercutaneous vertebroplasty.J Vasc Interv Radiol,2006,17(1):71-76.
  • 7Hayashi Y,Bone diseases with Pain.Osteoporosis Clin Calcium,2007,17(4):606-612.
  • 8田征,田禾,王翀,屈建华.比较经皮椎体成形术与保守治疗治疗骨质疏松性椎体压缩骨折的系统评价[J].中国骨质疏松杂志,2008,14(6):396-401. 被引量:18
  • 9Lyritis GP,Paspati I,Karachalios T.Pain relief from nasalsalmon calcitonin in osteoporotic vertebral crush fractures.Adouble blind,placebo-controlled clinical study.Acta OrthopScand Suppl,1997,275:112-114.
  • 10Takahashi S,Goldring S,Katz M,et al.Downregulation of calcitoninreceptor mRNA expression by calcitonin during human osteoclast-likecell differentiation.J Clin Invest,1995,95(1):167-171.

二级参考文献14

  • 1Watts NB, Harris ST, Genant HK. Treatment of painful osteoporotic vertebral fractures with percutaneous vertebroplasty or kyphoplasty. Osteoporos International, 2001,12(6) :429-437.
  • 2Mirovsky Y, Anekstein Y, Shalmon E, et al. Int radiscal cement leak following percutaneous vertebroplasty. Spine, 2006, 31:1120- 1124.
  • 3Cockerill W, Lunt M, Silman A J, et al. Health-related quality of life and radiographic vertebral fracture. Osteoporos Int, 2004, 15 : 113- 119.
  • 4Adachi JD, Loannidis G, Berger C, et al. Canadian Multicentre Osteoporosis Study (CaMos) Research Group: the influence of osteoporotic fractures on health-related quality of life in community- dwelling men and women across Canada. Osteoporos Int, 2001,12: 903-908.
  • 5Oleksik A, Lips P, Dawson A, et al. Health-related quality of life in postmenopausal women with low BMD with or without prevalent vertebral fractures. J Bone Miner Res, 2000,15 : 1354-1392.
  • 6Silverman SL. The clinical consequences of vertebral compression fracture. Bone, 1992, 13(2): 27-31.
  • 7Kado DM, Browner WS, Palermo L, et al. Vertebral fractures and mortality in older women: a prospective study. Arch intern Med, 1999, 159: 487-492.
  • 8Cooper C, Atkinson E J, O'Fallon WM, et al. Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester.J Bone Miner Res, 1992, 7: 221-227.
  • 9Joni P, Altman DG, Egger M. Assessing the quality of controlled clinical trials. British Medical Journal,2001,323(7303) :42-46.
  • 10Diamond TH, Champion B, Clark WA. Management of acute osteoporotic vertebral fractures: a nonrandomized trial comparing percutaneous vertebmplasty with conservative therapy. Am J Med, 2003,114 : 326-328.

共引文献17

同被引文献205

引证文献20

二级引证文献229

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部